advertisement
Barthelmes D 23
Showing records 1 to 23 | Display all abstracts from Barthelmes D98867 Dexamethasone Implant for Diabetic Macular Oedema: 1-Year Treatment Outcomes from the Fight Retinal Blindness! Registry
Bhandari S
Ophthalmology and therapy 2022; 11: 797-810
98629 Hemiretinal vein occlusion 12-month outcomes are unique with vascular endothelial growth factor inhibitors: data from the Fight Retinal Blindness! Registry
Hunt AR; Nguyen V
British Journal of Ophthalmology 2023; 107: 842-848
98867 Dexamethasone Implant for Diabetic Macular Oedema: 1-Year Treatment Outcomes from the Fight Retinal Blindness! Registry
Gabrielle PH
Ophthalmology and therapy 2022; 11: 797-810
98629 Hemiretinal vein occlusion 12-month outcomes are unique with vascular endothelial growth factor inhibitors: data from the Fight Retinal Blindness! Registry
Arnold JJ
British Journal of Ophthalmology 2023; 107: 842-848
98867 Dexamethasone Implant for Diabetic Macular Oedema: 1-Year Treatment Outcomes from the Fight Retinal Blindness! Registry
Nguyen V; Daien V
Ophthalmology and therapy 2022; 11: 797-810
98629 Hemiretinal vein occlusion 12-month outcomes are unique with vascular endothelial growth factor inhibitors: data from the Fight Retinal Blindness! Registry
McAllister IL
British Journal of Ophthalmology 2023; 107: 842-848
98867 Dexamethasone Implant for Diabetic Macular Oedema: 1-Year Treatment Outcomes from the Fight Retinal Blindness! Registry
Viola F
Ophthalmology and therapy 2022; 11: 797-810
98629 Hemiretinal vein occlusion 12-month outcomes are unique with vascular endothelial growth factor inhibitors: data from the Fight Retinal Blindness! Registry
Mehta H
British Journal of Ophthalmology 2023; 107: 842-848
98867 Dexamethasone Implant for Diabetic Macular Oedema: 1-Year Treatment Outcomes from the Fight Retinal Blindness! Registry
Viola F
Ophthalmology and therapy 2022; 11: 797-810
98629 Hemiretinal vein occlusion 12-month outcomes are unique with vascular endothelial growth factor inhibitors: data from the Fight Retinal Blindness! Registry
Invernizzi A
British Journal of Ophthalmology 2023; 107: 842-848
98867 Dexamethasone Implant for Diabetic Macular Oedema: 1-Year Treatment Outcomes from the Fight Retinal Blindness! Registry
Bougamha W
Ophthalmology and therapy 2022; 11: 797-810
98629 Hemiretinal vein occlusion 12-month outcomes are unique with vascular endothelial growth factor inhibitors: data from the Fight Retinal Blindness! Registry
Ponsioen T
British Journal of Ophthalmology 2023; 107: 842-848
98867 Dexamethasone Implant for Diabetic Macular Oedema: 1-Year Treatment Outcomes from the Fight Retinal Blindness! Registry
Young S; Romero-Nuñez B
Ophthalmology and therapy 2022; 11: 797-810
98629 Hemiretinal vein occlusion 12-month outcomes are unique with vascular endothelial growth factor inhibitors: data from the Fight Retinal Blindness! Registry
Gabrielle PH
British Journal of Ophthalmology 2023; 107: 842-848
98867 Dexamethasone Implant for Diabetic Macular Oedema: 1-Year Treatment Outcomes from the Fight Retinal Blindness! Registry
Figueras-Roca M
Ophthalmology and therapy 2022; 11: 797-810
98629 Hemiretinal vein occlusion 12-month outcomes are unique with vascular endothelial growth factor inhibitors: data from the Fight Retinal Blindness! Registry
O'Toole L; Kusenda P
British Journal of Ophthalmology 2023; 107: 842-848
98867 Dexamethasone Implant for Diabetic Macular Oedema: 1-Year Treatment Outcomes from the Fight Retinal Blindness! Registry
Zarranz-Ventura J
Ophthalmology and therapy 2022; 11: 797-810
98629 Hemiretinal vein occlusion 12-month outcomes are unique with vascular endothelial growth factor inhibitors: data from the Fight Retinal Blindness! Registry
Alforja S
British Journal of Ophthalmology 2023; 107: 842-848
98867 Dexamethasone Implant for Diabetic Macular Oedema: 1-Year Treatment Outcomes from the Fight Retinal Blindness! Registry
Barthelmes D; Sararols L
Ophthalmology and therapy 2022; 11: 797-810
98629 Hemiretinal vein occlusion 12-month outcomes are unique with vascular endothelial growth factor inhibitors: data from the Fight Retinal Blindness! Registry
Barthelmes D
British Journal of Ophthalmology 2023; 107: 842-848
98867 Dexamethasone Implant for Diabetic Macular Oedema: 1-Year Treatment Outcomes from the Fight Retinal Blindness! Registry
Gillies M
Ophthalmology and therapy 2022; 11: 797-810
98629 Hemiretinal vein occlusion 12-month outcomes are unique with vascular endothelial growth factor inhibitors: data from the Fight Retinal Blindness! Registry
Gillies MC
British Journal of Ophthalmology 2023; 107: 842-848
98867 Dexamethasone Implant for Diabetic Macular Oedema: 1-Year Treatment Outcomes from the Fight Retinal Blindness! Registry
Creuzot-Garcher C
Ophthalmology and therapy 2022; 11: 797-810
